May 22 (Reuters) - Ironwood Pharmaceuticals Inc said on Monday it would acquire Switzerland-based drug developer VectivBio Holding AG in a deal valued at about $1 billion, including debt. (Reporting by Raghav Mahobe in Bengaluru; Editing by Janane Venkatraman)
1st Jan change | Capi. | |
---|---|---|
+31.37% | 588B | |
-2.79% | 364B | |
+20.41% | 326B | |
+5.47% | 285B | |
+14.83% | 239B | |
+9.93% | 210B | |
-6.95% | 200B | |
+10.90% | 167B | |
+0.11% | 161B |